B
Beta Bionics, Inc. (BBNX)
NGM – Real Time Price. Currency in USD
9.82
-0.03 (-0.30%)
At close: May 12, 2026, 4:00 PM EDT
9.82
0.00 (0.00%)
After-hours: May 12, 2026, 4:10 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NGM – Real Time Price. Currency in USD
9.82
-0.03 (-0.30%)
At close: May 12, 2026, 4:00 PM EDT
9.82
0.00 (0.00%)
After-hours: May 12, 2026, 4:10 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 10.69 | 3.40 | 10 | |
| Quick ratio | 9.67 | 2.52 | 10 | |
| Debt to Equity | 0.03 | 1.11 | 9.0 | |
| Debt to Assets | 0.02 | 1.58 | 9.0 | |
| Interest coverage | N/A | 4.33 | 1.0 | |
| Weighted average score | 7.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 179K | 12M | 65M | 100M | 110M |
| Gross Profit | -2M | 6M | 36M | 56M | 63M |
| Operating Income | -66M | -36M | -45M | -72M | -77M |
| Net Income | -65M | -44M | -55M | -73M | -66M |
| EBITDA | -64M | -34M | -43M | -69M | -74M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 35.56 | -52.05 | 5.5 |
| Next quarter | 28.74 | -68.18 | 5.5 |
| Current year | 33.29 | -22.04 | 5.5 |
| Next year | 34.99 | 2.31 | 6.5 |
| Weighted average score | 5.8 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -13.98 | -62.58 | -63.32 | -139.39 | 1.0 |
| Y/Y | 56.62 | 23.59 | 47.31 | -24.12 | 7.8 |
| 3y average | 2366 | -8.64 | N/A | -6.64 | 3.3 |
| 5y average | N/A | N/A | N/A | N/A | 1.0 |
| Weighted average score | 3.3 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Company's cash reserves $30.3M significantly exceed its total debt $6.9M, ensuring strong financial flexibility
Total current assets $248.0M exceed Total current liabilities $23.2M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (1.1), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$25.2M limits the company's ability to reinvest or pay down debt